Top Markets
#1 Akedo Akedo +60.74%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.82%
#8 Bitway Bitway +17.84%
#9 Perle Perle +15.44%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.42%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Clasificación en acciones #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Precio por acción
$1.51
Última sincronización: 2024-08-26
Capitalización bursátil
$1.12M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Agile Therapeutics, Inc. (AGRX)

Categoría

Healthcare
Ingresos de Agile Therapeutics, Inc. (AGRX)
Ingresos en Jun 2024 TTM: $21.57M
Según los últimos informes financieros de Agile Therapeutics, Inc., los ingresos actuales de la empresa (TTM) son $21.57M. En 2022, la empresa obtuvo unos ingresos de $10.88M un aumento con respecto a los ingresos del año 2021, que fueron de $4.10M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Agile Therapeutics, Inc. desde 2012 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $21.57M 10.08%
2023 $19.59M 80.02%
2022 $10.88M 165.40%
2021 $4.10M 447.53%
2020 $749.00K 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B 30,554.91%
IN